News Ticker

[ February 3, 2023 ] Gracell Biotechnologies Announces FDA Clearance of the IND Application for Phase 1b/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Relapsed/Refractory Multiple Myeloma News
[ February 3, 2023 ] Engineer II – Roche – Carlsbad, CA San Diego Biotech Jobs
[ February 3, 2023 ] Director, Global Commercial Operations, Nucleic Acid Therapeutics – Thermo Fisher Scientific – Carlsbad, CA San Diego Biotech Jobs
[ February 3, 2023 ] Data Scientist – Roche – Carlsbad, CA San Diego Biotech Jobs
[ February 3, 2023 ] Cancer Research Assistant – UC San Diego – San Diego, CA San Diego Biotech Jobs

AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology

November 7, 2019 sandiegobiotech News Comments Off

AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology

00:00 /

SAN DIEGO–(BUSINESS WIRE)–AvantGen Announces Strategic Collaboration to Develop NK Cell Engager Technology

Copyright © 2022 Biotech Networks, LLC